Skip to main content
Clinical Trials/NCT04383392
NCT04383392
Unknown
Not Applicable

A Cross-over Randomized Controlled Trial of Quality of Life Between Cardiovascular Implantable Electronic Device With and Without Rate Adaptive Pacing

National Taiwan University Hospital Hsin-Chu Branch1 site in 1 country74 target enrollmentFebruary 1, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pacemaker DDD
Sponsor
National Taiwan University Hospital Hsin-Chu Branch
Enrollment
74
Locations
1
Primary Endpoint
Short-Form 36 Questionnaire
Last Updated
5 years ago

Overview

Brief Summary

Clinical implantable electronic devices, such as permanent pacemaker, implantable cardioverter defibrillator and cardiac resynchronization therapy are used in current daily practice for patients with bradycardia, ventricular arrhythmia, or heart failure. The rapid progress of permanent pacemaker function is growing to replace human's degenerating electrophysiology of heart.

The ability of physical work is an important cornerstone of quality of life. In daily activities, rate response to higher rate is importance for patients with bradycardia who can not accelerate their heart rate. And rate-adapting pacing of permanent pacemaker is a design to increase heart rate pacing according to physical activity or emotional activity. Patients with rate-adaptive pacing will get more cardiac output and overcome the physical activity such as stair climbing. But there are few studies to evaluate whether the rate-adaptive pacing of permanent pacemaker will improve the quality of life in people with bradycardia. The aim of this study is to compare turn-on with turn-off this function (DDDR vs DDD) whether rate-adaptive pacing will improve quality of life in patients with permanent pacemakers.

Registry
clinicaltrials.gov
Start Date
February 1, 2016
End Date
December 1, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
National Taiwan University Hospital Hsin-Chu Branch
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • sick sinus syndrome for permanent dual-chamber pacing
  • pacemakers are implanted for ≥30 days with no complications.

Exclusion Criteria

  • (1) patient or legal representative could not provide written informed consent
  • (2) unwillingness or inability to return for follow-up visits or reason to believe that adherence to follow-up visits wound be irregular,
  • (3) current or scheduled enrollment in other, conflicting studies,
  • (4) concomitant disease or other medical condition likely to result in death within 6 months, and

Outcomes

Primary Outcomes

Short-Form 36 Questionnaire

Time Frame: 3 months

The SF-36 questionnaire consists of eight health concepts (1) physical functioning, (2) role limitations due to physical health, (3) bodily pain, (4) general health perceptions, (5) vitality (energy/fatigue), (6) social functioning, (7) role limitations due to emotional health, (8) general mental health (psychological distress/wellbeing) which are expressed as a score on a 0-100 scale for each of the eight health concepts. The maximum score of 100 means no disability in five of the scales (Physical Functioning, Role Physical, Bodily Pain, Social Functioning, and Role Emotional) and indicates not the absence of disability, but the presence of a positive state of health in the other scales (General Health, Vitality and Mental Health).

Secondary Outcomes

  • 6 minute walking test(3 months)
  • NYHA functional class(3 months)

Study Sites (1)

Loading locations...

Similar Trials